FibroBiologics (FBLG) Research & Development (2023 - 2026)
FibroBiologics' Research & Development came in at $1.66 million for Q2 2026, down 18.8% from $2.04 million a year earlier and down 43.9% from the prior quarter.
Powered by 
Analysis
FibroBiologics (FBLG) Research & Development (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, FibroBiologics reported Research & Development of $8.2 million, up 28.3% year-over-year; for FY2025, it came in at $7.41 million, up 64.5% from FY2024.
- Research & Development has increased in each of the last three years, with a three-year compound annual growth rate of 86.2% (FY2022 to FY2025).
- Going back by year, Research & Development was $4.5 million in FY2024 (+90.2%), $2.37 million in FY2023 (+106.5%) and $1.15 million in FY2022.
- The five-year range for quarterly Research & Development is $478,000 (Q1 2023) to $2.95 million (Q1 2026).
- Year-over-year, Research & Development increased in six of the last eight quarters, with growth averaging 64.8%.
- The fastest year-over-year change in Research & Development over five years came in Q3 2025 (growth of 129.9%), and the weakest in Q4 2025 (a decline of 41.2%).
- Business Quant data shows FBLG's Research & Development at $2.95 million (Q1 2026), $797,000 (Q4 2025) and $2.79 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | FibroBiologics | 8.66 Mn | 8.66 Mn | - | 1.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.66 Mn |
| Mar 31, 2026 | 2.95 Mn |
| Dec 31, 2025 | 797,000.00 |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 975,000.00 |
| Mar 31, 2024 | 960,000.00 |
| Dec 31, 2023 | 773,000.00 |
| Sep 30, 2023 | 571,000.00 |
| Jun 30, 2023 | 547,000.00 |
| Mar 31, 2023 | 478,000.00 |
API Access
FibroBiologics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=FBLG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "FBLG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=FBLG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();